BD Single-Cell Multi-Omics user meeting seminar series. Part 4 – Single-cell expression…

Single-Cell Multi-Omics BD Rhapsody™

Part 4 – Single-cell expression profiling of mesenchymal stromal cells: Initial experience using BD Rhapsody™

In the fourth and final seminar from the BD Multi-Omics user meeting, Dr. Alison Devonshire from the National Measurement Laboratory, United Kingdom, talks about the use of the BD Multi-Omics technology for the expression profiling of mesenchymal stromal cells (MSC). MSCs are plastic-adherent, multipotent, self-renewing cells that express a specific set of cell-surface antigens that can differentiate into adipocytes, chondrocytes and osteocytes when cultured in-vitro.1 They can also be both pro- and anti-inflammatory, and can migrate and support tumorigenesis. The minimal criteria for defining MSC markers have been laid down by the International Society of Cellular Therapy (ISCT).2 However, many of the suggested markers are controversial (CD34), heterogeneous or found in contaminating cultures.

As a part of the project ‘De-risking of Regenerative Medicine’, Dr. Devonshire and her team have attempted to define new critical quality attributes (CQA) for MSCs . They have also attempted to monitor the stability of MSC associated markers and the response to inflammatory cytokines. Following the identification of cells with ISCT positive and negative markers using improved barcoding techniques, Dr. Devonshire and her team have used the BD Rhapsody™ Human Immune Response Panel to evaluate the expression of numerous genes. In addition to single-cell RNA sequencing, they also used flow cytometry and secretory profiles to evaluate marker expression. They have concluded that the BD Rhapsody™ Human Immune Response Panel shows promise in monitoring a range of CQAs for stem-cell-based products.

 

1.Schachtele S, Clouser C, Aho J, Markers and Methods to Verify Mesenchymal Stem Cell Identity, Potency, and Quality [White paper], Retrieved November 13, 2019, from R&D Systems – Biotechne.com: https://www.rndsystems.com/resources/articles/markers-and-methods-verify-mesenchymal-stem-cell-identity-potency-and-quality#Introduction
2. Dominici M, Le Blanck K, Mueller I et.al Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement (2006). Cytotherapy.;8(4):315-7
BD, the BD Logo and BD Rhapsody™ are trademarks of Becton, Dickinson and Company © 2019 BD and its subsidiaries. All rights reserved.
Products For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Newsletter

Do not miss any essential information join us :)

Send me the Flowcytometry News newsletter. I expressly agree to receive the newsletter and know that I can easily unsubscribe at any time.

Diary

Stay up to date on what happens in Flowcytometry News !

Register and receive our newsletter each month

Send me the Flowcytometry News newsletter. I expressly agree to receive the newsletter and know that I can easily unsubscribe at any time.